HPC Offered for PRESERVE Expansion (HOPE)

Ossium Health

Status: Enrolling

Conditions: Bone Marrow Transplant (BMT)

Treatments: Other: Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)

Study type: Observational

Funder types: Industry

Identifiers

NCT07145411

HOPE

HOPE Program

Details and patient eligibility

About

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product

Enrollment: 10 estimated patients

Sex: All

Ages: 12 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Patients aged 12-80 may be eligible* to receive bone marrow for transplantation through the Ossium HOPE Program if:

Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outweighs the potential risks

Trial design

10 participants in 1 patient group

Ossium HPC, Marrow

Description:

Ossium HPC, Marrow will be provide for infusion on the day of transplant

Treatment:

Other: Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)